Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Circulation

Background: In the randomized COAPT trial, among 614 heart failure (HF) patients with 3+ or 4+ secondary mitral regurgitation (MR), transcatheter mitral valve repair (TMVr) with the MitraClip reduced